Abstract
Hypermethylation of CpG islands in gene promoter regions has been shown to be a predictive biomarker for certain diseases. Most current methods for methylation profiling are not well-suited for clinical analysis. Here, we report the development of an inexpensive device and an epigenotyping assay with a format conducive to multiplexed analysis.
Original language | English |
---|---|
Pages (from-to) | 3695-3701 |
Number of pages | 7 |
Journal | The Analyst |
Volume | 139 |
Issue number | 15 |
DOIs | |
State | Published - 30 Jun 2014 |